Showing results (2181-2190 of 2,234) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|August 2, 2012
Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathwaysCheng-zhen Liang, Xin Zhang, Hao Li, et al.Cancer Biotherapy & Radiopharmaceuticals|June 19, 2012
Role of urokinase plasminogen activator receptor in gastric cancer: a potential therapeutic targetYing-Yu Ma, Hou-Quan TaoCancer Biotherapy & Radiopharmaceuticals|July 19, 2012
Evaluation of cyclin-dependent kinase-like 1 expression in breast cancer tissues and its regulation in cancer cell growthLi Tang, Yanfang Gao, Feng Yan, et al.Cancer Biotherapy & Radiopharmaceuticals|January 29, 2015
Tumor protein D52-like 2 contributes to proliferation of breast cancer cellsMei Yang, Xueyao Wang, Jiaoyuan Jia, et al.Cancer Biotherapy & Radiopharmaceuticals|April 15, 2022
Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal RadiopharmaceuticalsAmir R Jalilian, Arman Shahi, Ian P Swainson, et al.Cancer Biotherapy & Radiopharmaceuticals|June 30, 2018
Salubrinal Enhances Doxorubicin Sensitivity in Human Cholangiocarcinoma Cells Through Promoting DNA DamageWenjing Yu, Yuancai Xiang, Guosong Luo, et al.Cancer Biotherapy & Radiopharmaceuticals|June 20, 2018
Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5EYongbo Song, Chao Song, Sixing YangCancer Biotherapy & Radiopharmaceuticals|January 24, 2014
Gallium-68 DOTATOC PET/CT in vivo characterization of somatostatin receptor expression in the prostateMila V Todorović-Tirnanić, Milan M Gajić, Vladimir B Obradović, et al.Cancer Biotherapy & Radiopharmaceuticals|October 20, 2012
Phase I-II study of radiopeptide 177Lu-octreotate in combination with capecitabine and temozolomide in advanced low-grade neuroendocrine tumorsPhillip G Claringbold, Richard A Price, J Harvey TurnerCancer Biotherapy & Radiopharmaceuticals|August 2, 2021
Responsible Radionuclide Cancer CareJ Harvey TurnerPageof 224